China Universal Asset Management Company’s Acumen Pharmaceuticals ABOS Stock Holding History

China Universal Asset Management Company’s Portfolio ABOS Stock Details ABOS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-1,481	Closed	-$6.15K	–	426
2023 Q3	$6.15K	Buy	1,481 +943	+175%	+$5.83K	﹤0.01%	378
2023 Q2	$2.59K	Sell	538 -17	-3%	-$81	﹤0.01%	415
2023 Q1	$2.25K	Buy	555 +139	+33%	+$726	﹤0.01%	427
2022 Q4	$2.25K	Buy	416 +37	+10%	+$249	﹤0.01%	363
2022 Q3	$4K	Buy	+379	New	+$2.17K	﹤0.01%	284

Other funds holding ABOS

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

SCV

Sands Capital Ventures Arlington, Virginia $421M AUM 26.25% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

LCM

Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

KIA

Knollwood Investment Advisory Hunt Valley, Maryland $992M AUM 28.95% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

China Universal Asset Management Company's ABOS Position: Q4 2023 in Review

China Universal Asset Management Company sold out of Acumen Pharmaceuticals (ABOS) in Q4 2023, closing a stake of 1,481 shares — an estimated $6.15K sold.

China Universal Asset Management Company first reported a position in ABOS in Q3 2022 and held it in 5 quarters. The position peaked at $6.15K in Q3 2023. 67 funds tracked by Wall St. Rank hold ABOS as of Q4 2023.

China Universal Asset Management Company reported no remaining Acumen Pharmaceuticals position as of Q4 2023 after selling out during the quarter.
China Universal Asset Management Company sold 1,481 Acumen Pharmaceuticals shares in Q4 2023, an estimated $6.15K.
China Universal Asset Management Company first reported a position in Acumen Pharmaceuticals in Q3 2022 and held it in 5 quarters.
China Universal Asset Management Company's Acumen Pharmaceuticals position peaked at $6.15K in Q3 2023.
67 funds tracked by Wall St. Rank held Acumen Pharmaceuticals as of Q4 2023.

Based on China Universal Asset Management Company's 13F filing for Q4 2023, filed 24 Jan 2024.